Clinical Trial Update: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous Mircera for anemia in dialysis patients has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia of Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-02-15